Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
JD.com
JD
|
+$326M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$271M |
| 3 |
Merck
MRK
|
+$241M |
| 4 |
Intuitive Surgical
ISRG
|
+$237M |
| 5 |
Walmart
WMT
|
+$226M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.04B |
| 2 |
Amazon
AMZN
|
+$1.01B |
| 3 |
Tesla
TSLA
|
+$813M |
| 4 |
IAC Inc
IAC
|
+$756M |
| 5 |
Microsoft
MSFT
|
+$655M |
Sector Composition
| 1 | Technology | 24.22% |
| 2 | Healthcare | 13.86% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Financials | 11.5% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Weyco Group
WEYS
$286M
| $384K | ﹤0.01% |
23,734
+288
| +1% | +$4.66K |
|
|
DZSI
3002
DELISTED
DZS Inc. Common Stock
DZSI
| $384K | ﹤0.01% |
41,056
+17,530
| +75% | +$164K |
|
3003
Cidara Therapeutics
CDTX
$1.6B
| $382K | ﹤0.01% |
6,697
-1,448
| -18% | -$82.6K |
|
|
NYMX
3004
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $382K | ﹤0.01% |
155,495
-18
| -0% | -$44 |
|
3005
Crawford & Co Class A
CRD.A
$516M
| $380K | ﹤0.01% |
58,020
+12,330
| +27% | +$80.8K |
|
3006
Arq
ARQ
$301M
| $380K | ﹤0.01% |
93,599
+30,187
| +48% | +$123K |
|
3007
HBT Financial
HBT
$813M
| $377K | ﹤0.01% |
33,669
-4,595
| -12% | -$51.5K |
|
3008
BioSig Technologies, Inc. Common Stock
BSGM
$145M
| $375K | ﹤0.01% |
7,610
+846
| +13% | +$41.7K |
|
3009
BCB Bancorp
BCBP
$149M
| $373K | ﹤0.01% |
46,610
-28
| -0.1% | -$224 |
|
3010
Emerald Holding
EEX
$986M
| $373K | ﹤0.01% |
183,006
-34,424
| -16% | -$70.2K |
|
3011
Lifetime Brands
LCUT
$91.8M
| $372K | ﹤0.01% |
39,402
-55
| -0.1% | -$519 |
|
|
RVLP
3012
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $368K | ﹤0.01% |
68,015
+45,115
| +197% | +$244K |
|
3013
Janus Henderson
JHG
$6.91B
| $366K | ﹤0.01% |
16,844
+1,601
| +11% | +$34.8K |
|
|
AVEO
3014
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $366K | ﹤0.01% |
61,636
+27,656
| +81% | +$164K |
|
|
ESSA
3015
DELISTED
ESSA Bancorp
ESSA
| $365K | ﹤0.01% |
29,540
+139
| +0.5% | +$1.72K |
|
3016
Unity Bancorp
UNTY
$522M
| $364K | ﹤0.01% |
31,480
+408
| +1% | +$4.72K |
|
|
TYME
3017
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $360K | ﹤0.01% |
367,060
+2,992
| +0.8% | +$2.93K |
|
3018
Verrica Pharmaceuticals
VRCA
$47.2M
| $358K | ﹤0.01% |
4,626
+395
| +9% | +$30.6K |
|
3019
Maui Land & Pineapple Co
MLP
$335M
| $357K | ﹤0.01% |
32,979
+172
| +0.5% | +$1.86K |
|
3020
CASI Pharmaceuticals
CASI
$36.3M
| $356K | ﹤0.01% |
23,266
+5,099
| +28% | +$78K |
|
3021
Evolus
EOLS
$478M
| $356K | ﹤0.01% |
91,184
+19,546
| +27% | +$76.3K |
|
3022
Gencor Industries
GENC
$223M
| $348K | ﹤0.01% |
31,532
| – | – |
|
|
STR
3023
DELISTED
Sitio Royalties
STR
| $348K | ﹤0.01% |
35,707
-4,589
| -11% | -$44.7K |
|
|
PHAS
3024
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $347K | ﹤0.01% |
98,702
+66,347
| +205% | +$233K |
|
|
MR
3025
DELISTED
Montage Resources Corporation Common Stock
MR
| $347K | ﹤0.01% |
78,951
+1,944
| +3% | +$8.54K |
|